- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 5/22 - Human cells
Patent holdings for IPC class C12N 5/22
Total number of patents in this class: 219
10-year publication summary
|
17
|
26
|
20
|
21
|
16
|
11
|
11
|
4
|
2
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Trustees of the University of Pennsylvania | 4304 |
14 |
| President and Fellows of Harvard College | 5942 |
5 |
| Kyoto University | 2790 |
5 |
| Nanjing Legend Biotech Co., Ltd. | 163 |
5 |
| Inscripta, Inc., FORMERLY Muse Biotechnology, Inc. | 309 |
5 |
| The Regents of the University of California | 19803 |
4 |
| Chase Therapeutics Corporation | 38 |
4 |
| The Johns Hopkins University | 5637 |
3 |
| The Trustees of Columbia University in the City of New York | 3558 |
3 |
| The Brigham and Women's Hospital, Inc. | 2166 |
3 |
| Morehouse School of Medicine | 152 |
3 |
| Wake Forest University Health Sciences | 717 |
3 |
| BGI Shenzhen | 492 |
3 |
| Shenzhen Biocan Technologies Co., Ltd. | 147 |
3 |
| Massachusetts Institute of Technology | 10002 |
2 |
| Board of Regents, The University of Texas System | 5745 |
2 |
| Georgia Tech Research Corporation | 2709 |
2 |
| Adelaide Research & Innovation Pty Ltd | 96 |
2 |
| The Australian National University | 194 |
2 |
| Cellectis | 405 |
2 |
| Other owners | 144 |